HTX 0.00% 0.1¢ healthlinx limited

Anterior gradient homolog 2 (AGR2) is still in the testing phase...

  1. 13 Posts.
    Anterior gradient homolog 2 (AGR2) is still in the testing phase as far as I can tell. AGR2 is the one they were talking about as been able to test for other cancers including prostate (as well as increasing the effectiveness of OvPlex).

    Some of the information is listed on there website plus some serious web searching.

    Its all speculation at this stage like with any investment and as such always do your own research. I don't expect anything to happen overnight, I believe (again speculation) that it will happen soon. If your looking to buy and make a quick buck overnight then you should probably not as it is still relatively high risk (you could get lucky though). But if your looking for a medium to long term investment then I don't see a problem. I have also noted that there has been some other big buys recently which usually indicates that there is an interest.

    Remember scientific research, testing and introduction to the market takes time so patience is a must.

    REMEMBER ALWAYS DO YOUR OWN RESEARCH. :)
 
watchlist Created with Sketch. Add HTX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.